只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-16 2026-07-20 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN TenPercentOwner | 买入（P） | 116,671 | US$3.56 | US$415,348.76 | 7,030,000 | SEC |
| 2026-07-16 2026-07-20 | FULC Fulcrum Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC TenPercentOwner | 买入（P） | 116,671 | US$3.56 | US$415,348.76 | 7,030,000 | SEC |
| 2026-07-15 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN TenPercentOwner | 买入（P） | 107,377 | US$3.56 | US$382,262.12 | 6,913,329 | SEC |
| 2026-07-15 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC TenPercentOwner | 买入（P） | 107,377 | US$3.56 | US$382,262.12 | 6,913,329 | SEC |
| 2026-07-14 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN TenPercentOwner | 买入（P） | 53,651 | US$3.56 | US$190,997.56 | 6,730,000 | SEC |
| 2026-07-14 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC TenPercentOwner | 买入（P） | 53,651 | US$3.56 | US$190,997.56 | 6,730,000 | SEC |
| 2026-07-14 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN TenPercentOwner | 买入（P） | 75,952 | US$3.58 | US$271,908.16 | 6,805,952 | SEC |
| 2026-07-14 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC TenPercentOwner | 买入（P） | 75,952 | US$3.58 | US$271,908.16 | 6,805,952 | SEC |
| 2026-07-13 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN TenPercentOwner | 买入（P） | 12,966 | US$3.54 | US$45,899.64 | 6,676,349 | SEC |
| 2026-07-13 2026-07-15 | FULC Fulcrum Therapeutics, Inc. | TANG CAPITAL MANAGEMENT LLC TenPercentOwner | 买入（P） | 12,966 | US$3.54 | US$45,899.64 | 6,676,349 | SEC |
| 2026-07-13 2026-07-14 | FULT FULTON FINANCIAL CORP | Wenger E Philip Director | 卖出（S） | 5,000 | US$24.14 | US$120,713.50 | 75,477 | SEC |
| 2026-06-26 2026-06-30 | FULC Fulcrum Therapeutics, Inc. | Ezekowitz Alan Director | 卖出（S） | 18,000 | US$3.65 | US$65,700.00 | 10,927 | SEC |
| 2026-06-02 2026-06-03 | FLGT Fulgent Genetics, Inc. | Gao Hanlin Officer · Chief Scientific Officer | 卖出（S） | 1,688 | US$17.89 | US$30,198.32 | 990,374 | SEC |
| 2026-06-02 2026-06-03 | FLGT Fulgent Genetics, Inc. | Xie Jian Officer · President and COO | 卖出（S） | 2,146 | US$17.89 | US$38,391.94 | 367,605 | SEC |
| 2026-05-27 2026-05-28 | FLGT Fulgent Genetics, Inc. | Gao Hanlin Officer · Chief Scientific Officer | 卖出（S） | 945 | US$17.60 | US$16,632.00 | 992,062 | SEC |
| 2026-05-27 2026-05-28 | FLGT Fulgent Genetics, Inc. | Xie Jian Officer · President and COO | 卖出（S） | 1,201 | US$17.60 | US$21,137.60 | 369,751 | SEC |
| 2026-05-22 2026-05-26 | USNA USANA HEALTH SCIENCES INC | FULLER GILBERT A Director | 卖出（S） | 1,057 | US$18.66 | US$19,723.62 | 0 | SEC |
| 2026-05-04 2026-05-05 | FULT FULTON FINANCIAL CORP | Myers Curtis J Director,Officer · Chairman & CEO | 卖出（S） | 30,748 | US$21.26 | US$653,702.48 | 224,173.1 | SEC |
| 2026-04-13 2026-04-14 | FULT FULTON FINANCIAL CORP | Wenger E Philip Director | 卖出（S） | 5,000 | US$21.42 | US$107,100.00 | 80,477 | SEC |
| 2026-04-07 2026-04-07 | SNFCA SECURITY NATIONAL FINANCIAL CORP | FULLER GILBERT A Director | 卖出（S） | 10,000 | US$9.45 | US$94,500.00 | 31,973 | SEC |
| 2026-04-07 2026-04-07 | FUL FULLER H B CO | Mastin Celeste Beeks Director,Officer · President and CEO | 买入（P） | 5,170 | US$57.08 | US$295,103.60 | 8,670 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| FUL | 117,403.7108 | 0 | 264,506.5387 | 44.39% | B, Q, N |
| FULT | 188,047.4915 | 64 | 436,708.5632 | 43.06% | Q, N |
| MFUL | 24 | 0 | 56.5205 | 42.46% | Q |
| FULC | 402,142 | 0 | 1,984,681.5931 | 20.26% | B, Q, N |
| FULTP | 619 | 0 | 6,058.2258 | 10.22% | Q |